Phosphoinositide 3‐kinase δis a regulatory T‐cell target in cancer immunotherapy-Reference-Cited by-同舟云学术

Phosphoinositide 3‐kinase δis a regulatory T‐cell target in cancer immunotherapy

Published:2019-06-21 Issue:3 Volume:157 Page:210-218
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Lim Ee Lyn¹^ORCID,Okkenhaug Klaus²^ORCID

Affiliation:

1. Laboratory of Experimental Immunology Immunology Frontier Research Centre Osaka University Suita Japan

2. Division of Immunology Department of Pathology University of Cambridge Cambridge UK

Funder

Wellcome Trust

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13082

Reference134 articles.

1. Tumor Regulatory T Cells Potently Abrogate Antitumor Immunity

2. Regulatory T cells in cancer immunotherapy

3. Immunologic self‐tolerance maintained by activated T cells expressing IL‐2 receptor alpha‐chains (CD25). Breakdown of a single mechanism of self‐tolerance causes various autoimmune diseases;Sakaguchi S;J Immunol Baltim Md1950,1995

4. Tumour-associated macrophages as treatment targets in oncology

5. The Terminology Issue for Myeloid-Derived Suppressor Cells

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon;Neoplasia;2024-11

2. Cascade STING activation of a ternary immunostimulant for colorectal cancer eradication via photodynamic DNA damage and T regulatory cell inhibition;Chemical Engineering Journal;2024-10

3. Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12

4. Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP;Blood Advances;2023-07-18

5. Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model;Experimental and Therapeutic Medicine;2023-03-30